- Home
- LRMR vs NBB Comparison
LRMR vs NBB Comparison
Compare LRMR & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- NBB
- Stock Information
- Founded
- LRMR N/A
- NBB 2009
- Country
- LRMR United States
- NBB United States
- Employees
- LRMR N/A
- NBB N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- NBB Finance Companies
- Sector
- LRMR Health Care
- NBB Finance
- Exchange
- LRMR Nasdaq
- NBB Nasdaq
- Market Cap
- LRMR 426.9M
- NBB 478.3M
- IPO Year
- LRMR N/A
- NBB N/A
- Fundamental
- Price
- LRMR $3.34
- NBB $15.45
- Analyst Decision
- LRMR Strong Buy
- NBB
- Analyst Count
- LRMR 8
- NBB 0
- Target Price
- LRMR $19.63
- NBB N/A
- AVG Volume (30 Days)
- LRMR 678.8K
- NBB 73.9K
- Earning Date
- LRMR 03-13-2025
- NBB 01-01-0001
- Dividend Yield
- LRMR N/A
- NBB 8.64%
- EPS Growth
- LRMR N/A
- NBB N/A
- EPS
- LRMR N/A
- NBB N/A
- Revenue
- LRMR N/A
- NBB N/A
- Revenue This Year
- LRMR N/A
- NBB N/A
- Revenue Next Year
- LRMR N/A
- NBB N/A
- P/E Ratio
- LRMR N/A
- NBB N/A
- Revenue Growth
- LRMR N/A
- NBB N/A
- 52 Week Low
- LRMR $3.01
- NBB $13.67
- 52 Week High
- LRMR $13.68
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- LRMR 29.00
- NBB 48.82
- Support Level
- LRMR $3.24
- NBB $15.24
- Resistance Level
- LRMR $3.54
- NBB $15.38
- Average True Range (ATR)
- LRMR 0.22
- NBB 0.19
- MACD
- LRMR 0.03
- NBB 0.06
- Stochastic Oscillator
- LRMR 12.26
- NBB 98.18
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests primarily in a diversified portfolio of taxable municipal securities.